Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Frackiewicz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Endometriosis: an overview of the disease and its treatmentE J Frackiewicz
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorderE J Frackiewicz, T M Shiovitz
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|December 9, 2000
Women's health care during the perimenopauseE J Frackiewicz, N R Cutler
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
Clinical Therapeutics|May 1, 1997
Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxietyJ J Sramek, E J Frackiewicz, N R Cutler
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Clinical Neuropharmacology|June 5, 2003
First clinical evaluation of ganstigmine in patients with probable Alzheimer's diseaseS S Jhee, Laura Fabbri, A Piccinno, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adultsD E Salazar, E J Frackiewicz, R Dockens, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Endometriosis: an overview of the disease and its treatmentE J Frackiewicz
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorderE J Frackiewicz, T M Shiovitz
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|December 9, 2000
Women's health care during the perimenopauseE J Frackiewicz, N R Cutler
The Annals of Pharmacotherapy|February 11, 2000
Gender differences in depression and antidepressant pharmacokinetics and adverse eventsE J Frackiewicz, J J Sramek, N R Cutler
Expert Opinion on Investigational Drugs|November 4, 2000
Review of the acetylcholinesterase inhibitor galanthamineJ J Sramek, E J Frackiewicz, N R Cutler
Clinical Therapeutics|May 1, 1997
Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxietyJ J Sramek, E J Frackiewicz, N R Cutler
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Clinical Neuropharmacology|June 5, 2003
First clinical evaluation of ganstigmine in patients with probable Alzheimer's diseaseS S Jhee, Laura Fabbri, A Piccinno, et al.
Journal of Clinical Pharmacology|January 5, 2002
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adultsD E Salazar, E J Frackiewicz, R Dockens, et al.
Pageof 1